OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
William Martino will lead business development, driving strategy and growth for Ashfield Health and Mind+Matter, an Ashfield Health agency.
MassBio’s latest Biopharma Funding Report shows Massachusetts biopharma companies raised record-breaking $5.8 billion in VC Funding in 2020.
Prescription opioid Use in the U.S. has declined by 60% from 2011 Peak, according to new report from IQVIA.
Ashfield and IPCAA join forces to find out what HCPs really think about virtual medical congresses in new global study.
AI-powered platform can transform medical expert and opinion leader engagement planning for medical affairs teams.
Pharmaceutical R&D industry report provides insights into what’s behind decline in global NME outputs and reveals implications of decreased projected expenditures.
A technology-enabled solution combining predictive analytics integrated with real-time commercial services for the life sciences sector.
Review platform launches in light of new research which reveals that 93% lack trust in pharma companies.
Filippo Petti is CEO of Celyad Oncology tells Pharm Exec how the pandemic has affected his role as a US-based CEO to a Belgian company.
Bioscience firm applies AI and data science to identify existing drugs Atozet and Cablivi as potentially effective therapies for blood clots and inflammation caused by COVID-19.